Dataset Information


Automated planning through robust templates and multicriterial optimization for lung VMAT SBRT of lung lesions.

ABSTRACT: PURPOSE:To develop and validate a robust template for VMAT SBRT of lung lesions, using the multicriterial optimization (MCO) of a commercial treatment planning system. METHODS:The template was established and refined on 10 lung SBRT patients planned for 55 Gy/5 fr. To improve gradient and conformity a ring structure around the planning target volume (PTV) was set in the list of objectives. Ideal fluence optimization was conducted giving priority to organs at risk (OARs) and using the MCO, which further pushes OARs doses. Segmentation was conducted giving priority to PTV coverage. Two different templates were produced with different degrees of modulation, by setting the Fluence Smoothing parameter to Medium (MFS) and High (HFS). Each template was applied on 20 further patients. Automatic and manual plans were compared in terms of dosimetric parameters, delivery time, and complexity. Statistical significance of differences was evaluated using paired two-sided Wilcoxon signed-rank test. RESULTS:No statistically significant differences in PTV coverage and maximum dose were observed, while an improvement was observed in gradient and conformity. A general improvement in dose to OARs was seen, which resulted to be significant for chest wall V30 Gy , total lung V20 Gy , and spinal cord D0.1 cc . MFS plans are characterized by a higher modulation and longer delivery time than manual plans. HFS plans have a modulation and a delivery time comparable to manual plans, but still present an advantage in terms of gradient. CONCLUSION:The automation of the planning process for lung SBRT using robust templates and MCO was demonstrated to be feasible and more efficient.

SUBMITTER: Marrazzo L 

PROVIDER: S-EPMC7324702 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5864687 | BioStudies
2013-01-01 | S-EPMC3562272 | BioStudies
2012-01-01 | S-EPMC3338464 | BioStudies
1000-01-01 | S-EPMC6266684 | BioStudies
1000-01-01 | S-EPMC5690185 | BioStudies
1000-01-01 | S-EPMC6194601 | BioStudies
2015-01-01 | S-EPMC4650319 | BioStudies
2018-01-01 | S-EPMC5774747 | BioStudies
2013-01-01 | S-EPMC3798329 | BioStudies
2019-01-01 | S-EPMC6697352 | BioStudies